Form 4: Astera Labs CFO Michael Tate Sells Shares Under 10b5-1 Trading Plan

Michael Truett Tate, CFO of Astera Labs, Inc., sold shares of common stock on August 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On August 29, 2024, Michael Truett Tate, the Chief Financial Officer of Astera Labs, Inc. (ALAB), sold shares of the company's common stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 30, 2024.
• A total of 49,299 shares were sold at varying weighted average prices ranging from $44.26 to $49.87.
• Following the reported transactions, Tate directly owns 1,326,908 shares and indirectly owns 829,108 shares through the Tate Trust.
• The shares held in the Tate Trust are disclaimed as beneficially owned by Tate, except to the extent of any pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, as it simply reports transactions.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

• The share sales could have a minor negative impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates